Insider · CIK 0001417952
Robert N Fried
Files at NAGE (Niagen Bioscience, Inc.). First filing -, latest -.
In brief
Robert N Fried files SEC Form 4 as CEO and director at NAGE (Niagen Bioscience, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert N Fried has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | NAGE Niagen Bioscience, Inc. | AGrant or award Common Stock | +1,106 | $2.71 | $2,997 | 1,060,087 | Jul 8, 2026 |
| Apr 24, 2026 | NAGE Niagen Bioscience, Inc. | MOption exercise Common Stock | +20,000 | $2.61 | $52k | 1,058,981 | Apr 27, 2026 |
| Apr 24, 2026 | NAGE Niagen Bioscience, Inc. | MOption exercise Stock Options (right to buy)derivative | -20,000 | $0.00 | $0 | 0 | Apr 27, 2026 |
| Feb 19, 2026 | NAGE Niagen Bioscience, Inc. | AGrant or award Employee Stock Options (right to buy)derivative | +503,937 | $0.00 | $0 | 503,937 | Feb 24, 2026 |
| Apr 9, 2025 | NAGE Niagen Bioscience, Inc. | MOption exercise Common Stock | +66,667 | $3.30 | $220k | 1,038,981 | Apr 9, 2025 |
| Apr 9, 2025 | NAGE Niagen Bioscience, Inc. | MOption exercise Stock Options (right to buy)derivative | -66,667 | $0.00 | $0 | 0 | Apr 9, 2025 |
| Feb 25, 2025 | NAGE Niagen Bioscience, Inc. | AGrant or award Performance Stock Unitderivative | +1,518,600 | $0.00 | $0 | 1,518,600 | Feb 27, 2025 |
| Feb 12, 2025 | NAGE Niagen Bioscience, Inc. | AGrant or award Employee Stock Options (right to buy)derivative | +492,278 | $0.00 | $0 | 492,278 | Feb 14, 2025 |
Questions about Robert N Fried
Answered from the filings on this page, as of the latest one.
Is Robert N Fried buying or selling?
Robert N Fried has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert N Fried's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert N Fried has 0.
Where does Robert N Fried file Form 4?
Robert N Fried has filed Form 4 at NAGE (Niagen Bioscience, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.